• OPEN AN ACCOUNT
Indian Indices
Nifty
25,104.25 1.05
(0.00%)
Sensex
82,391.72 -53.49
( -0.06%)
Bank Nifty
56,629.10 -210.50
( -0.37%)
Nifty IT
38,300.00 630.80
( 1.67%)
Global Indices
Nasdaq
42,777.23 -6.65
(-0.02%)
Dow Jones
6,025.66 4.30
(0.07%)
Hang Seng
38,198.63 110.06
(0.29%)
Nikkei 225
8,832.28 -5.63
(-0.06%)
Forex
USD-INR
85.75 -0.02
(-0.02%)
EUR-INR
97.72 -0.17
(-0.18%)
GBP-INR
115.95 -0.20
(-0.17%)
JPY-INR
0.59 0.00
(-0.36%)

EQUITY - MARKET SCREENER

Aristo Bio-Tech & Lifescience Ltd
Industry :  Pesticides / Agrochemicals - Indian
BSE Code
ISIN Demat
Book Value()
76744
INE082101010
54.8309292
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ARISTO
21.05
85.54
EPS(TTM)
Face Value()
Div & Yield %
5.97
10
0.4
 

ashok leyl& ltd
Ashok Leyland gains as total sales rises 6% YoY in Mar’25
Apr 01,2025
The company’s total domestic sales jumped 6.24% YoY to 22,510 units in the month of March.

Domestic sales of medium and heavy commercial vehicles (M&HCV) advanced 11.78% to 16,082 units, while sales of light commercial vehicles (LCV) fell by 5.47% to 6,428 units in March 2025 compared to March 2024.

Ashok Leyland is engaged in the manufacture and sale of a wide range of commercial vehicles. The company also manufactures engines for industrial and marine applications, forgings, and castings.

The company’s consolidated net profit surged 36% to Rs 761.92 crore in Q3 FY25 as against Rs 560.21 crore posted in Q3 FY24. Revenue from operations rose 8.2% to Rs 11,946.15 crore in the quarter ended 31 December 2024.